Canada Pension Plan Investment Board’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,708
Closed -$1.73M 1191
2020
Q2
$1.73M Sell
1,708
-495
-22% -$460K ﹤0.01% 780
2020
Q1
$1.91M Sell
2,203
-261
-11% -$259K 0.01% 737
2019
Q4
$2.64M Sell
2,464
-1,661
-40% -$1.7M 0.01% 786
2019
Q3
$3.81M Sell
4,125
-1,379
-25% -$1.51M 0.01% 722
2019
Q2
$6.22M Buy
5,504
+3,164
+135% +$3.46M 0.01% 673
2019
Q1
$3.18M Buy
2,340
+496
+27% +$673K 0.01% 900
2018
Q4
$2.13M Buy
+1,844
New +$2.07M ﹤0.01% 955
2018
Q2
Sell
-2,008
Closed -$2.32M 1255
2018
Q1
$2.32M Buy
+2,008
New +$2.64M ﹤0.01% 953

Other funds holding KYNB

Canada Pension Plan Investment Board's KYNB Position: Q3 2020 in Review

Canada Pension Plan Investment Board sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 1,708 shares — an estimated $1.73M sold.

Canada Pension Plan Investment Board first reported a position in KYNB in Q1 2018 and held it in 8 quarters. The position peaked at $6.22M in Q2 2019. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

  • Canada Pension Plan Investment Board reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,708 Kyntra Bio shares in Q3 2020, an estimated $1.73M.
  • Canada Pension Plan Investment Board first reported a position in Kyntra Bio in Q1 2018 and held it in 8 quarters.
  • Canada Pension Plan Investment Board's Kyntra Bio position peaked at $6.22M in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2020, filed 12 Nov 2020.